About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Cancer Treatment Reviews
›
Top Articles
Cancer Treatment Reviews
Radiology
,
Oncology
14.4
(top 1%)
Impact Factor
15.6
(top 1%)
extended IF
152
(top 2%)
H-Index
1.8K
authors
2.8K
papers
132.4K
citations
7.3K
citing journals
76.8K
citing authors
Most Cited Articles of Cancer Treatment Reviews
Title
Year
Citations
PI3K/Akt signalling pathway and cancer
2004
1.5K
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
2001
1.4K
Molecular mechanisms of resistance and toxicity associated with platinating agents
2007
1.2K
Osteosarcoma treatment - where do we stand? A state of the art review
2014
813
The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer
2013
797
Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review
2008
682
New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin
2009
638
Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials
1997
602
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
2009
601
Epidemiology of childhood cancer
2010
583
Management of toxicities of immune checkpoint inhibitors
2016
522
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
2003
497
Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
2018
489
Primary bone osteosarcoma in the pediatric age: state of the art
2006
484
Interleukin-6 signaling pathway in targeted therapy for cancer
2012
475
The management of brain metastases
2003
461
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy
2018
433
Leptomeningeal carcinomatosis
1999
419
Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies
2003
417
Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation
2003
410
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization
2011
407
The proteasome: structure, function, and role in the cell
2003
390
The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents
2011
378
Mitomycin C: a review
1976
373
The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant
2015
369
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.